UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1166) 1166
humans (1064) 1064
life sciences & biomedicine (1017) 1017
male (708) 708
cholesterol (583) 583
anticholesteremic agents - therapeutic use (573) 573
female (570) 570
anticholesteremic agents (567) 567
middle aged (472) 472
biological and medical sciences (397) 397
animals (376) 376
lipids (368) 368
medical sciences (354) 354
anticholesteremic agents - pharmacology (345) 345
adult (305) 305
aged (296) 296
statins (294) 294
cardiovascular disease (266) 266
abridged index medicus (264) 264
cholesterol, ldl - blood (249) 249
low density lipoproteins (243) 243
risk factors (226) 226
atherosclerosis (225) 225
hypercholesterolemia - drug therapy (213) 213
treatment outcome (196) 196
analysis (195) 195
hypercholesterolemia (187) 187
drug therapy (184) 184
cardiovascular system & cardiology (183) 183
anticholesteremic agents - administration & dosage (177) 177
research (174) 174
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (173) 173
lipoproteins (170) 170
cholesterol - blood (167) 167
general & internal medicine (167) 167
diabetes (165) 165
medicine, general & internal (165) 165
pharmacology & pharmacy (163) 163
immunology (159) 159
anticholesteremic agents - adverse effects (158) 158
cardiac & cardiovascular systems (158) 158
low density lipoprotein (149) 149
multidisciplinary sciences (149) 149
pharmacology. drug treatments (149) 149
science & technology - other topics (149) 149
atorvastatin calcium (147) 147
internal medicine (146) 146
medicine (142) 142
cardiovascular diseases (138) 138
research article (135) 135
mice (134) 134
medical research (130) 130
care and treatment (127) 127
science (121) 121
cardiovascular agents (120) 120
double-blind method (120) 120
ezetimibe (119) 119
physiological aspects (119) 119
clinical trials (118) 118
triglycerides (118) 118
health aspects (114) 114
inflammation (114) 114
hypercholesterolemia - blood (110) 110
proteins (110) 110
drug therapy, combination (108) 108
endocrinology & metabolism (103) 103
cardiovascular (102) 102
antilipemic agents (99) 99
atorvastatin (98) 98
coronary heart disease (96) 96
rats (95) 95
simvastatin (95) 95
cardiology (94) 94
rodents (94) 94
cardiology and cardiovascular medicine (92) 92
triglycerides - blood (92) 92
biochemistry & molecular biology (90) 90
cholesterol - metabolism (90) 90
metabolism (89) 89
patients (89) 89
biochemistry (88) 88
cell biology (88) 88
heptanoic acids - therapeutic use (88) 88
pyrroles - therapeutic use (88) 88
lipids - blood (87) 87
diet (86) 86
metabolic diseases (86) 86
diabetes mellitus (83) 83
cardiovascular diseases - prevention & control (82) 82
fundamental and applied biological sciences. psychology (82) 82
mortality (82) 82
cholesterol, hdl - blood (81) 81
studies (81) 81
blood cholesterol (80) 80
medicine, experimental (79) 79
cardiology. vascular system (76) 76
general and cellular metabolism. vitamins (76) 76
medicine & public health (76) 76
drugs (73) 73
type 2 diabetes (71) 71
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1502) 1502
German (8) 8
Japanese (6) 6
Spanish (5) 5
French (4) 4
Italian (2) 2
Portuguese (2) 2
Russian (2) 2
Danish (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1517 - 1526
Journal Article
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1118 - 1123
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539
Journal Article
Journal Article
Journal of controlled release, ISSN 0168-3659, 2010, Volume 148, Issue 3, pp. 303 - 310
Liposome | MHC class I | Angiogenesis | Inflammation | Statin | Cancer | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Genes, MHC Class I - drug effects | Humans | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Neoplasms - complications | Neoplasms - genetics | Inflammation - drug therapy | Angiogenic Proteins - immunology | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Pravastatin - therapeutic use | Cytokines - immunology | Pravastatin - pharmacology | Cell Survival - drug effects | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Inflammation - etiology | Neoplasms - drug therapy | Anticholesteremic Agents - pharmacokinetics | Animals | Anticholesteremic Agents - therapeutic use | Pravastatin - administration & dosage | Neoplasms - immunology | Anticholesteremic Agents - administration & dosage | Lipid Metabolism - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Liposomes | Anticholesteremic Agents - pharmacology | Pravastatin - pharmacokinetics | Proteins | Post-translational modification | Cell research | Care and treatment | Growth | Physiological aspects | Pravastatin | Tumors | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9858, pp. 2007 - 2017
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 12, pp. 1108 - 1118
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Proprotein Convertases - antagonists & inhibitors | Injections, Intravenous | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Hypercholesterolemia - drug therapy | Dose-Response Relationship, Drug | Injections, Subcutaneous | Serine Endopeptidases - immunology | Adult | Cholesterol, LDL - blood | Female | Hyperlipoproteinemia Type II - drug therapy | Drug Therapy, Combination | Pyrroles - therapeutic use | Proprotein Convertases - metabolism | Receptors, LDL - metabolism | Lipoproteins - blood | Anticholesteremic Agents - adverse effects | Proprotein Convertases - immunology | Hyperlipoproteinemia Type II - metabolism | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Least-Squares Analysis | Serine Endopeptidases - metabolism | Receptors, LDL - drug effects | Hypercholesterolemia - metabolism | Proprotein Convertase 9 | Drugs | Dose-response relationship (Biochemistry) | Hypercholesterolemia | Monoclonal antibodies | Cholesterol, LDL | Dosage and administration | Product/Service Evaluations | Research | Drug therapy | Health aspects | Studies | Lipoproteins (low density) | Kexin | Serine | Atorvastatin | Cardiovascular disease | Subtilisin | Low density lipoprotein | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article